Doctor not included: FDA approves first flu vaccine that can be taken at home

The FDA has approved the at-home use of a nasal spray flu vaccine, set to be available for the 2025 flu season. This is the first time flu vaccines can be administered outside healthcare settings. AstraZeneca's nasal spray, approved for ages 2 to 49, will be available online, costing $35 to $45 per dose. It is needle-free, addressing needle phobia in many Americans. The CDC recommends flu vaccination for everyone over six months, but current rates are low. An at-home option may boost these numbers. However, the flu mist is not suitable for pregnant or immunocompromised individuals.

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF